Neovision Capital
Overview
Neovision Capital is an investment fund that specializes in the venture capital investments in growth companies. The firm prefers to invest in the healthcare, information technology, TMT and consumer products and services sectors. The company leverages its team's extensive operational experience in China, along with international resources, to provide strategic support to its portfolio companies. This includes expertise in areas such as branding, marketing, channel development, overseas expansion, human resources, and finance. Neovision Capital also maintains a presence in Nanjing.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| BrioHealth Solutions | Jul 2025 | Series E | Lead |
| CH Biomedical | Jun 2025 | Series E | Co-investor |
| Sino-Biocan (Shanghai) Biotech Ltd | Mar 2024 | Series B | Co-investor |
| ALVA Systems | Dec 2021 | Series B | Co-investor |
| Xgene Pharmaceutical Inc. | Nov 2021 | Series C | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Neovision Capital based?
Neovision Capital is headquartered in Shanghai, Shanghai, China.
When was Neovision Capital founded?
Neovision Capital was founded in 2015.
How many portfolio companies does Neovision Capital have?
Neovision Capital has 13 portfolio companies in Caplight's dataset.
What are some companies in Neovision Capital's portfolio?
Recent investments visible on Caplight include BrioHealth Solutions, CH Biomedical, Sino-Biocan (Shanghai) Biotech Ltd, ALVA Systems, Xgene Pharmaceutical Inc..
What was Neovision Capital's most recent investment?
Neovision Capital's most recent investment on Caplight was in BrioHealth Solutions in 2025.
What sectors does Neovision Capital focus on?
Neovision Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Cybersecurity, Healthcare & Life Sciences, Cybersecurity, Healthcare & Life Sciences, FinTech, Frontier & Industrial Tech, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software, Enterprise Software, Enterprise Software, Enterprise Software, Enterprise Software, Enterprise Software.
What company stages does Neovision Capital focus on?
Neovision Capital typically invests at the Mid stage.
What is Neovision Capital's AUM?
Neovision Capital's assets under management are estimated between $100.0M and $250.0M.